Cohen LH, Vamos E, Heinrichs C, Toppet M, Courtens W, Kumps A, Mardens Y, Carlsson B, Grillner L, Larsson A: Growth failure, encephalopathy, and endocrine dysfunctions in two siblings, one with 5-oxoprolinase deficiency
Cerebrolysin is one of the most extensively studied neuropeptide preparations in clinical medicine, with data from more than 200 clinical trials and approximately 15,000 patients across multiple neurological conditions
it was a systematic effort to retain full agonist potency at the amylin receptors while adding pharmaceutical durability, and the resulting molecule is a potent agonist at both AMY receptor subtypes and the parent calcitonin receptor
It is also important to note that silymarin has been shown to have hypoglycemic effects, which may enhance the effects of antidiabetic medications, potentially leading to hypoglycemia [24]
R., Bigdeli, M